Dermatology

Dermatomyositis: Why an oral JAK inhibitor changes everything

The FDA approved Lisraya, the first oral Janus kinase inhibitor for dermatomyositis, offering a new systemic treatment option for this rare autoimmune disease.

Could immune system modulation be the next frontier in skincare?

Emerging research suggests that targeting immune pathways could offer novel strategies for managing chronic skin conditions, moving beyond symptomatic relief.

Why rosacea flushing resists standard therapy: a neurovascular disconnect

Rosacea's persistent flushing often fails to respond to conventional treatments, pointing to a deeper neurovascular dysregulation beyond simple inflammation.

Matching rosacea therapy to dominant features: A phenotype-led approach

Treating rosacea effectively requires identifying the dominant clinical features, as a phenotype-led approach can guide targeted therapy for optimal patient outcomes.

Does targeting Demodex mites improve rosacea outcomes?

Topical ivermectin significantly reduced inflammatory lesions in papulopustular rosacea, suggesting a role for Demodex mite modulation in treatment.

Antihistamine-refractory urticaria: when standard care falls short

Current guidelines for chronic urticaria recommend step-up therapy for patients who do not respond to standard antihistamine doses, escalating to higher doses or adding biologics.

Chronic Urticaria: The Diagnostic Tests That Rarely Help

Many tests for chronic urticaria offer little diagnostic value, often leading to unnecessary patient anxiety and cost. A focused history and physical examination remain paramount.

Remibrutinib: A New BTK Inhibitor for Chronic Urticaria Beyond Omalizumab

A novel BTK inhibitor, remibrutinib, offers a new therapeutic option for chronic spontaneous urticaria, moving beyond existing treatments like omalizumab.

Alopecia Areata: What happens when patients stop treatment?

Patients with alopecia areata often experience relapse or worsening of hair loss upon discontinuation of systemic therapies, highlighting the chronic nature of the disease and the need for sustained treatment.